1. NOOTROPIL is recommended for the symptomatic improvement of memory and intellectual impairment of a pathological nature in the absence of a diagnosis of dementia.
2. Studies have shown some improvement in children with learning difficulties associated with the written word, particularly with textual understanding which cannot be explained by intellectual backwardness, inadequate education or by the family environment. The administration of NOOTROPIL does not replace other measures also well adapted to correct these learning difficulties, such as remedial teaching.
3. NOOTROPIL can reduce myoclonus of cortical origin in some patients. In order to test the sensitivity to piracetam, trial treatment can therefore be instituted for a limited period.